Biochemical predictors that enhance tumor susceptibility to TNT include normal pretreatment CEA levels and absence of genetic mutations (wild type); however, the current quality of data for biochemical and genetic markers of pCR after TNT is low. This evidence concerns the gene CEACAM5 and neoplasm.